The Food and Drug Administration restored a top vaccine regulator to his position at the agency just weeks after firing him.

Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...

Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to his post, according to the Department of Health and Human Services ...

Novavax ( ($NVAX) ) has risen by 24.00%. Read on to learn why. Novavax has experienced a notable 24.00% increase in its stock price over the past ...

Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

Notably, Pfizer's Comirnaty COVID vaccine is still approved or authorized for people 6 months of age and older without any restrictions based on risk factors for COVID — at least for now. But the FDA ...

In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

COVID vaccines, including the new non-mRNA product Novavax, are safe and effective and decrease the burden of illness and ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

A research study from the United States suggests that bird flu could have spread amongst cattle through the air or ...

Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...

Federal vaccine policy changes under RFK Jr. have some concerned health insurance will not cover COVID shots. A bill in NY ...